Now, ”printer” that creates made-to-measure human organs

London, June 4 (ANI): Patients needing transplants would soon ask doctors to ”print” new organs for them, it has been claimed.

The California-based regenerative medicine company Organovo has already unveiled a prototype machine capable of growing new arteries.

Company bosses believe the technology could be used to create new organs.

The machine is based on 3D laser printing technology used to make new machine parts for industry.

But instead of combining layers of plastic and metal, the “bioprinter” puts together living tissue.

Two laser-based printing heads are used to place living cells onto thin sheets of gel with microscopic precision.

Thereafter, multiple layers are laid on top of each other in a specially designed “scaffold” and the cells begin to fuse together.

“Ultimately the idea would be for surgeons to have tissue on demand for various uses,” the Telegraph quoted Organovo”s chief executive Keith Murphy, as saying.

Murphy added: “The best way to do that is get a number of bio-printers into the hands of researchers and give them the ability to make three dimensional tissues on demand.” (ANI)

Body-piercing ritual at Kochi Temple

Kochi, Mar. 31 (ANI): Devotees at Kerala’s Aaryyankavu Bhagwathi Temple have devised a new way of performing the banned ancient Thookkam, or body-piercing ritual.

In the original Thookam ritual, the back of the person willing to perform the ritual is pierced with sharp hooks and lifted up to a height of over 30 feet on a scaffold, before the bleeding victim is brought down and hooks taken out.

However, the new method doesn’t require the devotee to be hung or lifted.

“After a court put a ban on the ancient ritual of multiple body-piercing and hanging from rope, now only single piercing is done in the body and the person just stands still and does not hang. The devotees also fast for 41 days,” said Shiv Raman, a temple committee member.

In 2004 – following a widespread protest by social activists and even Hindu priests – the practice was banned by a court.

The legend behind the ritual goes back to the ancient days. Legend has it that even after slaying the demon Darika, the Goddess Kali remained bloodthirsty.

Hindu god Lord Vishnu then sent his mount, the giant bird Garuda, to Kali. Garuda gave the goddess some drops of blood, which pacified her thirst.

The ritual is performed based on this belief. (ANI)

Body fat could act as a natural scaffold for tissue growth

Washington, Mar 26 (ANI): When Deepak Nagrath, the Indian-origin researcher at Rice University, threw away the sticky substance secreted by the cells while finding ways to grow cells in a scaffold, little did he know that it was the very thing he was looking for— body fat.

The substance, derived from adipose cells—body fat—turned out to be a natural extracellular matrix.

“I thought it was contamination, so I threw the plates away,” said Nagrath.

And since then, Nagrath and his colleagues have built a biological scaffold that allows cells to grow and mature.

He hopes the new material, when suffused with stem cells, will someday be injected into the human body, where it can repair tissues of many types without fear of rejection.

And the basic idea is simple—prompt fat cells to secrete what bioengineers call “basement membrane.”

The membrane mimics the architecture tissues naturally use in cell growth, literally a framework to which cells attach while they form a network.

When the cells have matured into the desired tissue, they secrete another substance that breaks down and destroys the scaffold.

Structures that support the growth of living cells into tissues are highly valuable to pharmaceutical companies for testing drugs in vitro. Companies commonly use Matrigel, a protein mixture secreted by mouse cancer cells, but for that reason it can”t be injected into patients.

“Fat is one thing that is in excess in the body. We can always lose it,” said Nagrath.

The substance derived from the secretions, called Adipogel, has proven effective for growing hepatocytes, the primary liver cells often used for pharmaceutical testing.

“My approach is to force the cells to secrete a natural matrix,” he said.

The matrix is a honey-like gel that retains the natural growth factors, cytokines and hormones in the original tissue.

Nagrath is convinced that his strategy is ultimately the most practical for rebuilding tissue in vivo, and not only because it may cost significantly less than Matrigel.

“The short-term goal is to use this as a feeder layer for human embryonic stem cells. It”s very hard to maintain them in the pluripotent state, where they keep dividing and are self-renewing,” he said.

Once that goal is achieved, Adipogel may be just the ticket for transplanting cells to repair organs.

“You can use this matrix as an adipogenic scaffold for stem cells and transplant it into the body where an organ is damaged. Then, we hope, these cells and the Adipogel can take over and improve their functionality,” said Nagrath.

The research appeared last week in the Federation of American Societies for Experimental Biology (FASEB) Journal. (ANI)

Bone Stem Cells can be used to mend damaged hips

London, Mar.20 (ANI): Bone stem cells could in future be used instead of bone from donors as part of an innovative new hip replacement treatment, according to scientists at the University of Southampton.

A team from the University’s School of Medicine believe that introducing a patient’s own skeletal stem cells into the hip joint during bone grafting would encourage more successful regrowth and repair.

The grafting technique is used to repair the thigh bone and joint during replacement (known as ”revision”) hip replacement therapy, a procedure in which surgeons introduce donor bone to the damaged area to provide support for the new hip stem.

In this collaborative study between the University of Southampton and The University of Nottingham, researchers will use adult stem cells from bone marrow in combination with an innovative impaction process and polymer scaffolds.

In a two-year study, funded by the Medical Research Council (MRC), researchers aim to improve the outcomes of this high impact procedure.

“Surgeons currently use bone from donors during bone grafting, so introducing a patient’s own stem cells to create a living cell or material composite would be a totally new approach,” comments Professor Richard Oreffo, an expert in musculoskeletal science at the University of Southampton, who is leading the project.

“This is very much the beginning of a project to investigate the potential for this new technique, but our preliminary work suggests this may have significant therapeutic implications.”

When a hip joint is damaged, part of the thigh bone or femur, including the ball, can be removed and a new, artificial joint fixed to the remaining thigh bone. Revision hip replacement occurs when that artificial joint needs to be changed.

Professor Oreffo will introduce the stem cells to the hip joint using a scaffold, or support structure, which is designed to protect them, and a new impaction process. The polymer scaffolds will be developed by Professors Steve Howdle and Kevin Shakesheff, experts in chemistry and tissue engineering at the University of Nottingham.

Professor Howdle explains: “Building upon strong collaborations with tissue engineering experts, this new grant will allow researchers at Nottingham to take their materials nearer to the clinic.

“This could have great benefits for patients, and also offer a significant cost saving for healthcare authorities; but first we need to verify and build upon our preliminary data.”

“A major part of the work at Nottingham will involve scaling up the supercritical fluid processing apparatus to create larger and more uniform batches of polymer scaffolds for testing.”

Dr Chris Watkins, MRC’s Translation Theme Leader, says: “Resilience, repair and replacement is a priority research area in the MRC’s strategic plan, ‘Research Changes Lives’. This study highlights how a regenerative approach can offer real hope in addressing a significant problem for an ageing population.”

This funding will allow the groups to build on initial studies that show that degradable polymer scaffolds prepared using supercritical carbon dioxide technology can have a dramatic effect on surgical procedures, such as inserting a hip implant in revision hip surgery.

The provisional studies carried out in Southampton show that the polymers can aid bone formation through the creation of a living cell/material composite and aid attachment of the hip implant.

Natural hydrogel may boost spinal cord healing

Washington, Sep 18 (ANI): A jab of biomaterial gel into a spinal cord injury site may significantly improve healing, according to researchers at the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center.

Dr. Mark Preul and Dr. Alyssa Panitch have found in a study that injection of an engineered hydrogel made up mainly of hyaluronic acid (a naturally-occurring body substance) into the spinal cord injury site decreases scarring, and promotes a realignment of the spinal cord fibres around the injury site.

The hyaluronic acid, which forms a scaffold-like configuration may help to structurally stabilize the spinal cord injury site.

The researchers traced cells in the brain stem after injury, and found much higher levels in the hydrogel treated animals as compared to animals that did not receive the treatment, and approached nearly normal levels.

Treated animals had higher functional scores than their non-treated counterparts.

“Spinal cord injury is devastating to civilian and military populations – especially to the young. There has been little progress toward paradigms of regeneration and few results that show real, sustained functional recovery. We’ve been so pre-occupied with regeneration, but that is a highly complicated and difficult to define goal. This project is a synergy of neurosurgeons and bioengineers that attempts repair of the SCI lesion cavity using a tissue-engineering biomaterials approach,” says Preul.

He added that the team aimed at finding ways to structurally allow the body to better heal itself.

“In this project we did not add anything to the hyaluronic acid. It may be that adding growth factors or cells into the gel matrix may allow even better results,” he said.

Preul said that the results show “we may be on a practical path that can give hope to the many people who suffer this sort of injury.”

The work was presented at the Annual Meeting of the American Association of Neurological Surgeons in San Diego where it won the Synthes Prize for Spine Research. (ANI)

How plant tissues know which end is their growing tip

Washington, August 30 (ANI): A team of scientists has silenced nine genes in a multicellular organism, which allowed them to discover molecular secrets of how certain plant tissues know which end is their growing tip, also referred to as polarized growth.

The research was carried out by biologist Magdalena Bezanilla and colleagues at the University of Massachusetts Amherst, US.

The biologists conducted these experiments in a moss, but the findings illuminate processes in two tissues-root hairs and pollen tubes-found in all seed plants.

Root hairs are extremely fine individual cells that grow out of a plant’s root, greatly increasing its surface area to collect water, essential minerals and nutrients.

Pollen tubes travel down the flower to fertilize the plant’s egg.

Scientists have “a very limited knowledge” at the molecular level of how such cells determine the direction they’re growing, according to Bezanilla.

Knowing how to interrupt pollen tube formation in plants such as corn and soybeans, for example, could help prevent genetically engineered crops from interbreeding with wild populations.

Aiding root hair growth could boost drought-resistance to other economically important plants.he researchers focused on two proteins, actin and formin.

Actin, in this case a kind of scaffold-builder needed to form root hairs and pollen tubes, forms filamentous polymers and is important for many cellular processes in species ranging from yeast to man. ormins, like actin, are found in many species and help to control actin polymer formation. Formins are critical for actin-based cellular processes.

Tools in a biologist’s kit can now remove the function of specific proteins-usually one or two at a time-to silence a gene, but in this study, the researchers succeeded in silencing a remarkable nine genes at one time.

Bezanilla and colleagues systematically silenced the many actin-regulating formins and determined which members of this protein family are needed to generate cells for proper tip growth.ther tools in the researchers’ kit are methods for re-introducing the silenced genes, either normal or modified versions.

By “swapping parts” from closely related formin proteins and measuring tip growing activity for each combination, her research group eventually concluded that only one intact subclass of formins drives normal growth and controls how the plant recognizes its growing tip.

“If you take away any part of the formin, tip growth stops,” said Bezanilla.

Interestingly, the researchers also discovered that this particular subclass of formins is the fastest yet known in any organism. (ANI)

Jelly thickener may help grow artificial muscles in future

Melbourne, July 14 (ANI): In a novel study, Australian researchers are using food thickener used in yoghurts and jellies to develop artificial muscle.

Nanotechnology graduate Cameron Ferris, and supervisor Dr. Marc in het Panhuis, of the University of Wollongong, have developed a scaffold with the help of gellan gum-a biopolymer produced by the bacteria Pseudomonas elodea-that can help get cells to grow into the right kind of tissue.

“At home it’s used as a food additive. You’ll find it in lots of yoghurts and jellies as a thickener and emulsifier,” ABC Online quoted Ferris as saying.

Gellan gum is particularly useful because it becomes a gel at 37 degree Celsius, which is a good temperature for living cells, he adds.

Using the novel scaffold, the researchers are trying to develop artificial heart muscle that may soon be used to replace damaged parts of the heart in heart attacks patients.

“Muscle and heart need electrical stimulation for the cells to achieve their fully differentiated functioning state,” said Ferris.

To achieve this, Ferris has made a scaffold that mixes the gellan gum with carbon nanotubes, which conduct electricity.

To date, Ferris has successfully grown fibroblasts on his gellan gum and carbon nanotube scaffold but has “steered away” from using carbon nanotubes because of “unanswered questions” over their safety.

“Some (studies) say they’re fine and that they can be passed out of the body when the scaffold degrades,” he said.

“Others have said that they’re quite toxic to cells or can accumulate in the lungs,” he added.

The study has been published in the journal Soft Matter. (ANI)

Jelly thickener may help grow artificial muscles in future

Melbourne, July 14 (ANI): In a novel study, Australian researchers are using food thickener used in yoghurts and jellies to develop artificial muscle.

Nanotechnology graduate Cameron Ferris, and supervisor Dr. Marc in het Panhuis, of the University of Wollongong, have developed a scaffold with the help of gellan gum-a biopolymer produced by the bacteria Pseudomonas elodea-that can help get cells to grow into the right kind of tissue.

“At home it’s used as a food additive. You’ll find it in lots of yoghurts and jellies as a thickener and emulsifier,” ABC Online quoted Ferris as saying.

Gellan gum is particularly useful because it becomes a gel at 37 degree Celsius, which is a good temperature for living cells, he adds.

Using the novel scaffold, the researchers are trying to develop artificial heart muscle that may soon be used to replace damaged parts of the heart in heart attacks patients.

“Muscle and heart need electrical stimulation for the cells to achieve their fully differentiated functioning state,” said Ferris.

To achieve this, Ferris has made a scaffold that mixes the gellan gum with carbon nanotubes, which conduct electricity.

To date, Ferris has successfully grown fibroblasts on his gellan gum and carbon nanotube scaffold but has “steered away” from using carbon nanotubes because of “unanswered questions” over their safety.

“Some (studies) say they’re fine and that they can be passed out of the body when the scaffold degrades,” he said.

“Others have said that they’re quite toxic to cells or can accumulate in the lungs,” he added.

The study has been published in the journal Soft Matter. (ANI)

Now, a tissue scaffold that regrows cartilage, bone

Washington, May 12 (ANI): In a novel study, MIT scientists have developed a new tissue scaffold that can stimulate bone and cartilage growth when transplanted into the knees and other joints.

Lead researchers Lorna Gibson, of the MIT, and Professor William Bonfield, of Cambridge University, said that the scaffold could offer a potential new treatment for sports injuries and other cartilage damage, such as arthritis.

“If someone had a damaged region in the cartilage, you could remove the cartilage and the bone below it and put our scaffold in the hole,” said Gibson.

The scaffold has two layers, one that mimics bone and one that mimics cartilage. When implanted into a joint, the scaffold can stimulate mesenchymal stem cells in the bone marrow to produce new bone and cartilage.

The technology is currently limited to small defects, using scaffolds roughly 8 mm in diameter.

The study conducted using goats showed that the scaffold successfully stimulated bone and cartilage growth after being implanted in their knees.

Gibson said that the new scaffold could offer a more effective, less expensive, easier and less painful substitute for treating cartilage injuries.

The findings appear in the Journal of Biomedical Materials Research. (ANI)

First animals on Earth resembled blobs of gelatinous goo, reveal 850 mln yr old fossils

London, May 12 (ANI): Scientists have discovered 850 million year old fossil traces in Canadian rocks, which resembled blobs of gelatinous goo, that has potentially solved a major problem for the origin of animal life.

The previous oldest animal fossils date from “only” 650 million years ago, although “molecular clocks” based on rates of genetic divergence indicate that animals should have originated about 850 million years ago.

According to a report in New Scientist, the new findings may therefore help solve the problem of the 250 million-year-gap.

Palaeontologists have looked long and hard for traces left by the first multi-celled organisms, fully aware that the soft-bodies might have left very few fossils.

The breakthrough came when Elizabeth Turner, of Laurentian University in Sudbury, Ontario, spotted odd patterns in the rocks of 850-million-year-old limestone reefs in the Mackenzie Mountains of Canada’s Northwestern territory.

She has spent the last 15 years, with Fritz Neuweiler of University Laval in Quebec, trying to deduce their origin.

Now, Turner and Neuweiler, along with David Burdige of Old Dominion University in Virginia, have shown that the patterns match the distinctive textures found in reefs built by sponges.

Studies of modern sponges show that when their collagen structure decays it calcifies and leaves a signature pattern.

Since collagen is a fibrous protein found only in animals, some ancestral animal must have lived in the ancient reef, argue researchers.

The animal consisted of “cells living embedded in a scaffold of collagen, which they extruded to make their home,” said Turner.

“There probably were more than one type of cell, but we can’t tell. Nothing like it lives today, but if we saw one, it would look like a little blob of gelatinous goo,” she added.

The presence of animals this early in Earth’s history would resolve the long-standing disparity between molecular clocks and the fossil record, and show that the evolution of animals began before the Earth slipped twice into a global deep freeze.

“I applaud the approach of looking for distinctive textures seen along with sponge skeletons in younger rocks,” said Andrew Knoll of Harvard University. “It’s a good first step, but it’s not yet proof, he added. (ANI)

Potential therapeutic target for Alzheimer’s identified

Washington, Apr 28 (ANI): Researchers from the University of California, San Diego School of Medicine have identified a protein which, when over-expressed, leads to the formation of senile plaques that cause Alzheimer’s disease.

It can be a potential new therapeutic target to block the accumulation of amyloid plaque in the brain.

“The role of the multi-domain protein, RANBP9, suggests a possible new therapeutic target for Alzheimer’s disease,” said Dr David E. Kang, assistant professor of neurosciences at UC San Diego and director of this study.

The researchers identified the RANBP9 protein by studying low density lipoprotein receptor-related protein (LRP), a protein that rapidly shuttles Aß out of the brain and across the blood-brain barrier to the body, where it breaks down into harmless waste products.

“RANBP9 is one of the proteins we identified that interacted with this LRP segment, but one that had never before been associated with disease-related neuronal changes,” said Kang.

“We discovered that this protein interacts with three components involved in Aß generation – LRP, APP and BACE1 – and appears to ‘scaffold’ them into a structure,” he added.

When the scientists knocked out RANBP9 in the cell, 60pct less Aß was produced.

“Inhibiting the RANBP9 protein may offer an alternative approach to therapy, by preventing contact between APP and the enzyme that makes the cut essential to produce amyloid plaques.”

The researchers will be conducting further studies to verify these findings in animal models.

The study will be published in the Journal of Biological Chemistry. (ANI)

Scientists successfully use stem cells to replace stroke-damaged tissue in rats

Washington, March 9 (ANI): Scientists have achieved a significant success in using stem cells to replace stroke-damaged tissue in rats.

Led by Dr Mike Modo of King’s College London, the research project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC).

The study conducted at the Institute of Psychiatry and University of Nottingham has shown that by inserting tiny scaffolding with stem cells attached, it is possible to fill a hole left by stroke damage with brand new brain tissue within seven days.

Previous experiments, where stem cells have been injected into the void left by stroke damage, have had some success in improving outcomes in rats.

The problem is that in the damaged area, there is no structural support for the stem cells, and thus they tend to migrate into the surrounding healthy tissues instead of filling up the hole left by the stroke.

Dr. Modo said: “We would expect to see a much better improvement in the outcome after a stroke if we can fully replace the lost brain tissue, and that is what we have been able to do with our technique.”

The researcher used individual particles of a biodegradable polymer called PLGA, which had been loaded with neural stem cells, and filled stroke cavities with stem cells on a ready-made support structure.

“This works really well because the stem cell-loaded PLGA particles can be injected through a very fine needle and then adopt the precise shape of the cavity. In this process the cells fill the cavity and can make connections with other cells, which helps to establish the tissue,” Dr. Modo said.

“Over a few days we can see cells migrating along the scaffold particles and forming a primitive brain tissue that interacts with the host brain. Gradually the particles biodegrade leaving more gaps and conduits for tissue, fibres and blood vessels to move into,” the researcher added.

In the current study, the researchers used an MRI scanner to pinpoint precisely the right place to inject the scaffold-cell structure.

They say that the next stage of the research will be to include a factor called VEGF with the particles, which will encourage blood vessels to enter the new tissue. (ANI)

Now, ‘smart scaffolds’ to mend broken hearts

Washington, Jan 13 (ANI): Canadian scientists have created ‘smart scaffolds’ that can help the human body to repair broken heart tissues rather than just aid people to live with the weakened condition.

Usually treatments of heart disease or muscle loss can just help the body cope up with the chronic condition.

But, for the first time, researchers have developed an organic substance that attracts and supports cells necessary for tissue repair and can be directly injected into problem areas.

The advance can act as a major step toward treatments that allow people to more fully recover from injury and disease rather than having to live with chronic health problems.

Also, the treatment may help reduce the need for organ transplantation by allowing physicians to save organs that would have been previously damaged beyond repair.
eveloped by Erik Suuronen and his colleagues from the University of Ottawa and the Ottawa Heart Research Institute, the “smart scaffolds,” work because they contain a protein that allows progenitor cells to adhere to the damaged tissue and survive long enough to promote healing.

The cells emit homing signals that alert other cells to join in the process and give off chemical signals that order cells to grow blood vessels necessary for healing to occur.

“Ultimately, we envision a scaffold material that can be taken off the shelf and injected into the hearts of patients suffering from blocked arteries. The scaffold materials would direct the repair process, and restore blood flow and function to the heart,” said Suuronen.

For the study, the researchers tested the material in three groups of rats, with each group suffering from a lack of blood oxygen (ischemia) to their thigh muscles.

The muscles in the first group of rats were treated with the smart scaffold. The second group of rats received a scaffold not engineered for cell attachment. The third group received a placebo.

After two weeks of treatment, rats treated with the “smart” scaffold had more new blood vessels and better functional recovery while rats from the other two groups of rats only had minimal improvement.

“This is a major development toward radically new treatments for heart and muscle disease. If this research holds up in humans, it has the potential to save more lives than any other major advance in the field since the stent,” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal.

The study is published online in The FASEB Journal. (ANI)